C07D 211/84
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
C07D211/84 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 1,072 US grants and 588 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,072
- Published applications
- 588
- Assignees
- 460
- Inventors
- 2,452
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 26 | 0 |
| 1977 | 29 | 0 |
| 1978 | 22 | 0 |
| 1979 | 23 | 0 |
| 1980 | 12 | 0 |
| 1981 | 16 | 0 |
| 1982 | 12 | 0 |
| 1983 | 14 | 0 |
| 1984 | 20 | 0 |
| 1985 | 30 | 0 |
| 1986 | 28 | 0 |
| 1987 | 34 | 0 |
| 1988 | 37 | 0 |
| 1989 | 51 | 0 |
| 1990 | 35 | 0 |
| 1991 | 40 | 0 |
| 1992 | 29 | 0 |
| 1993 | 25 | 0 |
| 1994 | 21 | 0 |
| 1995 | 25 | 0 |
| 1996 | 19 | 0 |
| 1997 | 27 | 0 |
| 1998 | 23 | 0 |
| 1999 | 17 | 0 |
| 2000 | 20 | 0 |
| 2001 | 18 | 5 |
| 2002 | 26 | 30 |
| 2003 | 23 | 37 |
| 2004 | 15 | 34 |
| 2005 | 23 | 24 |
| 2006 | 13 | 34 |
| 2007 | 18 | 28 |
| 2008 | 9 | 16 |
| 2009 | 9 | 17 |
| 2010 | 18 | 27 |
| 2011 | 6 | 19 |
| 2012 | 19 | 11 |
| 2013 | 17 | 21 |
| 2014 | 16 | 24 |
| 2015 | 31 | 28 |
| 2016 | 16 | 18 |
| 2017 | 17 | 24 |
| 2018 | 16 | 28 |
| 2019 | 24 | 24 |
| 2020 | 17 | 22 |
| 2021 | 19 | 15 |
| 2022 | 18 | 23 |
| 2023 | 8 | 22 |
| 2024 | 15 | 18 |
| 2025 | 17 | 28 |
| 2026 | 9 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Small molecule RPN13 inhibitors with antitumor properties7 Jul 2026US 12,673,918 B2The Johns Hopkins University
- C3-carbon linked glutarimide Degronimers for target protein degradation21 Apr 2026US 12,605,450 B2C4 Therapeutics, Inc.
- Ionizable lipids and compositions and uses thereof24 Mar 2026US 12,583,817 B2Massachusetts Institute of Technology
- Degraders and degrons for targeted protein degradation10 Mar 2026US 12,570,626 B2C4 Therapeutics, Inc.
- Estrogen-receptor modulator and use thereof8 Oct 2026US 2026/0308139 A1Jiangsu Vcare PharmaTech Co., Ltd.
- Pdk1 regulatory compound and composition containing the same2 Jul 2026US 2026/0183274 A1Provibio Co., Ltd.
- Pdk1 regulatory compound and composition containing the same2 Jul 2026US 2026/0183302 A1Provibio Co., Ltd.
- Pdk1 regulatory compound and composition containing the same2 Jul 2026US 2026/0183303 A1Provibio Co., Ltd.
- Ionizable lipids and compositions and uses thereof2 Jul 2026US 2026/0184671 A1Massachusetts Institute of Technology
Most cited
By later US patents
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Cyclic amides171US 5,698,579 ACelgene Corporation · 1997
- Cyclic amides169US 5,877,200 ACelgene Corporation · 1999
- Pharmaceutically acceptable salts135US 4,879,303 APfizer Inc. · 1989
- Method of combatting coronary and vascular diseases96US 4,532,248 ABayer Aktiengesellschaft · 1985